Mode
Text Size
Log in / Sign up
N/A Completed N=950 Randomized Single-blind Prevention

Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery

Post Operative Delirium
Source: ClinicalTrials.gov NCT02213380 ↗
Enrolled (actual)
950
Serious AEs
0.5%
Results posted
Jan 2021
Primary outcomePrimary: Number of Participants With Post-operative Delirium in 7 Days Post Operation — 29; 24 Participants

Summary

The purpose of this study is evaluate postoperative delirium after general anesthesia and regional anesthesia in elderly patients undergoing hip fracture surgery. Our research hypotheses are: (1) regional anesthesia may contribute to decrease the incidence of postoperative delirium. (2) Regional anesthesia may improve the outcome of elderly patient and reduce healthcare costs associated with postoperative delirium. (3) Postoperative delirium may result in poor long-term functional outcomes.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Post-operative Delirium in 7 Days Post Operation
29; 24
SECONDARY
Number of Participants With Post-operative Delirium
16; 10; 5; 10; 8; 4
SECONDARY
Severity of Delirium
23.48; 24.22
SECONDARY
The Subtypes of Delirium Diagnosed in 7 Days Post Operation
16; 16; 2; 1; 2; 3
SECONDARY
30 Day Mortality
8; 4
SECONDARY
Acute Pain Score Using Visual Analogue Scale (VAS)
0; 0
SECONDARY
Length of Hospital Stay
7; 7
SECONDARY
Costs of Anesthetic Procedure
159; 268
SECONDARY
Total In-hospital Costs
5582; 5908
SECONDARY
6 Months Incidence of Delirium
SECONDARY
12 Months Incidence of Delirium
SECONDARY
6 Months Quality of Life
SECONDARY
12 Months Quality of Life

Eligibility Criteria

Inclusion Criteria

  • older patient (≥65 years)
  • patient with hip fracture and planned hip fracture surgery
  • patient willing to complete this study.

Exclusion Criteria

  • patient with multiple trauma or multiple fractures, pathological fractures, pelvic fractures, femur fractures
  • contraindication (serious illness or medical conditions) for general anesthesia
  • contraindication (infection at the site of needle insertion, coagulopathy, international normalized ratio >1.4, platelet count <80×109 litre-1, allergy to local anaesthetics and so on) for regional anesthesia;
  • patient who cannot complete the preoperative mental tests (CAM and/or Mini-Mental State Examination (MMSE)) of this clinical trial
  • patient known to susceptible to malignant hyperthermia
  • known allergy or hypersensitivity to any drugs administered during this clinical trial
  • previous participation in this clinical trial
  • participation in another clinical trial within 4 weeks prior to selection
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02213380). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search